OPKO Health Pre-Tax Profit Margin 2010-2024 | OPK
OPKO Health pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| OPKO Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $0.71B | $-0.12B | -16.57% |
| 2024-06-30 | $0.72B | $-0.24B | -34.03% |
| 2024-03-31 | $0.80B | $-0.25B | -31.13% |
| 2023-12-31 | $0.86B | $-0.18B | -21.18% |
| 2023-09-30 | $0.87B | $-0.21B | -24.57% |
| 2023-06-30 | $0.87B | $-0.26B | -30.07% |
| 2023-03-31 | $0.91B | $-0.33B | -36.25% |
| 2022-12-31 | $1.00B | $-0.39B | -38.94% |
| 2022-09-30 | $1.22B | $-0.36B | -29.10% |
| 2022-06-30 | $1.43B | $-0.20B | -13.88% |
| 2022-03-31 | $1.56B | $-0.12B | -7.89% |
| 2021-12-31 | $1.77B | $-0.01B | -0.79% |
| 2021-09-30 | $1.87B | $0.10B | 5.25% |
| 2021-06-30 | $1.91B | $0.09B | 4.61% |
| 2021-03-31 | $1.77B | $0.14B | 7.86% |
| 2020-12-31 | $1.44B | $0.05B | 3.41% |
| 2020-09-30 | $1.16B | $-0.11B | -9.02% |
| 2020-06-30 | $0.97B | $-0.19B | -19.27% |
| 2020-03-31 | $0.89B | $-0.28B | -31.91% |
| 2019-12-31 | $0.90B | $-0.30B | -33.74% |
| 2019-09-30 | $0.90B | $-0.30B | -33.04% |
| 2019-06-30 | $0.92B | $-0.27B | -29.78% |
| 2019-03-31 | $0.96B | $-0.21B | -22.23% |
| 2018-12-31 | $0.99B | $-0.18B | -17.86% |
| 2018-09-30 | $0.93B | $-0.23B | -24.73% |
| 2018-06-30 | $0.93B | $-0.25B | -26.89% |
| 2018-03-31 | $0.96B | $-0.27B | -28.69% |
| 2017-12-31 | $0.97B | $-0.27B | -28.05% |
| 2017-09-30 | $0.98B | $-0.18B | -18.75% |
| 2017-06-30 | $1.03B | $-0.16B | -15.66% |
| 2017-03-31 | $1.09B | $-0.11B | -9.71% |
| 2016-12-31 | $1.12B | $-0.10B | -8.68% |
| 2016-09-30 | $1.22B | $-0.06B | -4.50% |
| 2016-06-30 | $1.07B | $0.02B | 1.69% |
| 2016-03-31 | $0.75B | $-0.06B | -7.58% |
| 2015-12-31 | $0.49B | $-0.14B | -28.11% |
| 2015-09-30 | $0.24B | $-0.17B | -69.29% |
| 2015-06-30 | $0.12B | $-0.26B | -216.95% |
| 2015-03-31 | $0.10B | $-0.24B | -240.00% |
| 2014-12-31 | $0.09B | $-0.17B | -185.87% |
| 2014-09-30 | $0.09B | $-0.13B | -151.72% |
| 2014-06-30 | $0.09B | $-0.14B | -159.09% |
| 2014-03-31 | $0.09B | $-0.12B | -130.68% |
| 2013-12-31 | $0.10B | $-0.10B | -107.22% |
| 2013-09-30 | $0.09B | $-0.10B | -108.70% |
| 2013-06-30 | $0.08B | $-0.05B | -61.45% |
| 2013-03-31 | $0.07B | $-0.06B | -86.96% |
| 2012-12-31 | $0.05B | $-0.04B | -78.72% |
| 2012-09-30 | $0.04B | $-0.04B | -97.30% |
| 2012-06-30 | $0.03B | $-0.03B | -103.13% |
| 2012-03-31 | $0.03B | $-0.03B | -93.33% |
| 2011-12-31 | $0.03B | $-0.02B | -85.71% |
| 2011-09-30 | $0.03B | $-0.01B | -41.38% |
| 2011-06-30 | $0.03B | $-0.01B | -39.29% |
| 2011-03-31 | $0.03B | $-0.01B | -44.44% |
| 2010-12-31 | $0.03B | $-0.01B | -42.86% |
| 2010-09-30 | $0.02B | $-0.02B | -94.74% |
| 2010-06-30 | $0.02B | $-0.02B | -126.67% |
| 2010-03-31 | $0.01B | $-0.02B | -190.00% |
| 2009-12-31 | $0.00B | $-0.02B | -600.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.174B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |